Company intelligence / Profile preview

Acceligen

Eagan, Minnesota, United States
Ownership
Private
Employees
~4
Development stage
Other
01

Overview

Acceligen is a private animal biotechnology company focused on precision breeding and gene editing in food animals. The company develops and commercializes livestock traits intended to improve animal health, welfare, sustainability, and productivity, primarily in cattle, swine, aquaculture, and dairy systems. Publicly described programs include PRLR-SLICK cattle for heat tolerance and PRRSV-resistant pigs, alongside broader trait-development efforts for disease resilience and productivity. Acceligen operates as a wholly owned subsidiary of Recombinetics and works with reproductive-technology and regional commercialization partners to deploy edited traits into elite breeding lines. Its business is best characterized as agricultural and animal-health biotech rather than human therapeutics.

Therapeutic areas
ImmunologyOtherInfectious Diseases
Modalities
CRISPR-based therapyGene therapy
Industry
Agriculture & AgTech
02

Partnerships

Trans Ova GeneticsKheiron-BiotechBill & Melinda Gates Foundation

Beyond the preview

Go deeper on Acceligen.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Acceligen.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call